Sionna Therapeutics, Inc.

NASDAQ:SION

Biotechnology

Healthcare
$2.97 +1.85%

+$0.68 today

Market cap
$134.35M
Beta
1.29
P/E (TTM)
-19.7
EPS (TTM)
-$1.90
52W Low $13.81High $48.45

Volume 0.52M

Average 0.39M

SION Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

Sionna Therapeutics, Inc.NASDAQ: SION

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) growth accelerates

Q1 FY2026 weighted avg shares (diluted) of 44.92M shares rose 1.9% year over year, ahead of the -1.7% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 12.4% from the prior quarter. Over 3 fiscal years it compounded at -3.2% a year.

Context

  • Weighted avg shares (diluted) increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +1.9% holds above the trailing-twelve-month pace of -1.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
44.92M+12.4% QoQ
Last fiscal yearDec 2025
39.96M-9.4% YoY
LTMMar 2026
43.37M-1.7% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1.9%——
1 year-9.4%——
3-year CAGR-3.2%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
39.96M USD
Year-over-year change
-9.4%
3-year CAGR
-3.2%

Weighted Avg Shares (Diluted) vs competitors

How SION compares with its peers on the latest reported figures

  • SION's LTM Mar 2026 weighted avg shares (diluted) of 43.37M shares is the lowest of the 11 companies compared; the peer median is 90.83M shares.
  • Its year-over-year change of -1.7% is the lowest of 11, against a peer median of +9.1%.
  • Over three fiscal years its annual growth of -3.2% compares with a peer median of +13.3%.
SION Competitors Peer median
Weighted Avg Shares (Diluted) for SION and competitors
Company Period LTM YoY 3-year CAGR
ABCLAbCellera Biologics Inc.LTM Sep 2026306.35M +3.0%-1.7%
ARDXArdelyx, Inc.LTM Mar 2026242.83M +1.9%+15.0%
XERSXeris Biopharma Holdings, Inc.LTM Mar 2026172.82M +15.4%+8.4%
BHVNBiohaven Ltd.LTM Jun 2026131.06M +31.1%+34.0%
IMNMImmunome, Inc.LTM Sep 2026106.83M +34.8%+93.1%
ZYMEZymeworks Inc.LTM Sep 202674.82M -1.6%+4.9%
CLDXCelldex Therapeutics, Inc.LTM Sep 202672.36M +9.0%+12.4%
VERAVera Therapeutics, Inc.LTM Jun 202667.85M +14.4%+34.2%
JANXJanux Therapeutics, Inc.LTM Mar 202662.14M +9.2%+14.3%
MAZEMaze Therapeutics, Inc.LTM Mar 202646.63M +6.5%-0.6%
SIONSionna Therapeutics, Inc.LTM Mar 202643.37M -1.7%-3.2%
Peer median (excluding SION) 90.83M+9.1%+13.3%

Competitors are the stored peer set for SION. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue0000
Cost of Revenue00668K647K
Gross Profit00(668K)(647K)
Gross Margin————
Research & Development34.61M40.63M57.29M60.26M
Selling, General & Admin6.77M9.71M13.27M28.72M
Operating Expenses41.37M50.33M69.89M88.34M
Depreciation & Amortization122K583K668K647K
EBITDA(40.12M)(46.68M)(61.02M)(74.62M)
EBITDA Margin————
Operating Income(41.37M)(50.33M)(70.56M)(88.98M)
Operating Margin————
Interest Income1.13M2.77M8.17M13.3M
Interest Expense0000
Other Income / Expenses1.13M3.07M8.87M13.71M
Income Before Tax(40.24M)(47.26M)(61.69M)(75.27M)
Pre-Tax Margin————
Income Tax Expense0000
Net Income(40.24M)(47.26M)(61.69M)(75.27M)
Net Margin————
EPS (Basic)(0.91)(1.07)(1.40)(1.88)
EPS (Diluted)(0.91)(1.07)(1.40)(1.88)
Weighted Avg Shares44.12M44.12M44.12M39.96M
Weighted Avg Shares (Diluted)44.12M44.12M44.12M39.96M

Sionna Therapeutics, Inc.

NASDAQ:SION

Intrinsic Alpha fair value

Locked

Current Price

$2.97

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.